SHIELD THERAPEUTICS PLC — Investor Relations & Filings
Shield Therapeutics is a commercial-stage specialty pharmaceutical company focused on addressing iron deficiency. The company's mission is to improve the lives of patients suffering from this condition, with or without anemia. Its lead product is Accrufer® (ferric maltol), also marketed as Feraccru®, a novel, stable, non-salt-based oral therapy. This innovative pharmaceutical is broadly indicated for use in adults across multiple therapeutic categories, aiming to provide an effective and well-tolerated treatment for a significant unmet medical need.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Grant of Share Options | 2026-05-05 | English | |
| Q1 2026 Trading Update | 2026-05-01 | English | |
| Total Voting Rights | 2026-04-30 | English | |
| Enrollment in Phase II Clinical Trial for ACCRUFeR | 2026-04-27 | English | |
| Audited results for year ended 31 December 2025 | 2026-04-09 | English | |
| Publication of Report, Reinforcing FDA Approval | 2026-04-01 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41263201 | Grant of Share Options | 2026-05-05 | English | ||
| 39399233 | Q1 2026 Trading Update | 2026-05-01 | English | ||
| 39019036 | Total Voting Rights | 2026-04-30 | English | ||
| 37325589 | Enrollment in Phase II Clinical Trial for ACCRUFeR | 2026-04-27 | English | ||
| 33979107 | Audited results for year ended 31 December 2025 | 2026-04-09 | English | ||
| 33556496 | Publication of Report, Reinforcing FDA Approval | 2026-04-01 | English | ||
| 33102131 | Total Voting Rights | 2026-03-31 | English | ||
| 33101967 | EMA approves extension - to include adolescents | 2026-03-31 | English | ||
| 32869324 | Chinese NMPA Accepts MAA Submission for ACCRUFeR® | 2026-03-03 | English | ||
| 32843910 | Total Voting Rights | 2026-02-27 | English | ||
| 18023058 | FDA Grants additional Exclusivity for ACCRUFeR | 2026-02-09 | English | ||
| 13759127 | Total Voting Rights | 2026-01-30 | English | ||
| 13754859 | Approval for ACCRUFeR in China expected in Q1 2026 | 2026-01-30 | English | ||
| 13132786 | Q4 2025 Trading Update | 2026-01-21 | English | ||
| 11753277 | Block listing 6 Monthly Return | 2026-01-02 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for SHIELD THERAPEUTICS PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
89bio, Inc.
Clinical-stage biopharma developing therapies for liver and…
|
ETNB | US | Manufacturing |
|
Aardvark Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for hunger…
|
AARD | US | Manufacturing |
|
Aarey Drugs & Pharmaceuticals Ltd
Manufactures APIs and chemical intermediates for global pha…
|
AAREYDRUGS | IN | Manufacturing |
|
Aarti Drugs Limited
Produces APIs, pharma intermediates, and specialty chemical…
|
AARTIDRUGS | IN | Manufacturing |
|
Aarti Pharmalabs Limited
Manufacturer of APIs, intermediates, and xanthines with glo…
|
AARTIPHARM | IN | Manufacturing |
|
AAYUSH WELLNESS LIMITED
Develops and markets herbal formulations, supplements, and …
|
539528 | IN | Manufacturing |
|
Ab&B Bio-Tech CO., LTD. JS
Biopharmaceutical company engaged in the R&D and commercial…
|
2627 | HK | Manufacturing |
|
Abbisko Cayman Limited
Clinical-stage biopharma focused on discovering and develop…
|
2256 | KY | Manufacturing |
|
Abbott India Ltd.
Provides pharmaceutical solutions in gastroenterology, card…
|
ABBOTINDIA | IN | Manufacturing |
|
ABBOTT LABORATORIES
Global healthcare company in medical devices, diagnostics, …
|
ABT | US | Manufacturing |
SHIELD THERAPEUTICS PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7914/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7914 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7914 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7914 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7914}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SHIELD THERAPEUTICS PLC (id: 7914)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.